Candida albicans Antibodies (IgG, IgA, IgM)
Test Code
30440
86628 (x3)
Clinical Significance
Candida albicans Antibodies (IgG, IgA, IgM) - Candidiasis is a fungal infection that may cause localized or systemic disease. The severity of infection is broad extending to life threatening. Acute or convalescent titers should be compared.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Enzyme Linked Immunosorbent Assay (ELISA)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
This test is not available for New York patient testing.
This test is not available for New York patient testing.
Reference Range(s)
| C. albicans IgG | <1.0 |
| C. albicans IgA | <1.0 |
| C. albicans IgM | <1.0 |
Interpretive Criteria
| <1.0 | Antibody Not Detected |
| ≥1.0 | Antibody Detected |
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.2 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 14 days
- Frozen: 30 days
Reject Criteria
Hemolysis • Lipemia • Grossly contaminated • Icteric • Other body fluids
Setup Schedule
1 mL serum
0.2 mL
Transport tube
Room temperature
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Hemolysis • Lipemia • Grossly contaminated • Icteric • Other body fluids